Manager CAR-T Cell Collection Operations

Johnson & Johnson is currently seeking a Manager CAR-T Cell Collection Operations to join our TEAM! Remote work options may be considered on a case-by-case basis and if approved by the Company.

At Johnson & Johnson, we believe health is everything. Our strength in healthcare innovation empowers us to build a world where complex diseases are prevented, treated, and cured, where treatments are smarter and less invasive, and solutions are personal. Through our expertise in Innovative Medicine and MedTech, we are uniquely positioned to innovate across the full spectrum of healthcare solutions today to deliver the breakthroughs of tomorrow, and profoundly impact health for humanity. Learn more at https://www.jnj.com/.

For more than 130 years, diversity, equity & inclusion (DEI) has been a part of our cultural fabric at Johnson & Johnson and woven into how we do business every day. Rooted in Our Credo, the values of DEI fuel our pursuit to create a healthier, more equitable world. Our diverse workforce and culture of belonging accelerate innovation to solve the world’s most pressing healthcare challenges.

Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson, and Legend Biotech USA Inc., have entered into a global, strategic collaboration to develop, manufacture, and commercialize a chimeric antigen receptor (CAR) T-cell therapy. This innovative strategic partnership is designed to combine the strengths and expertise of two companies to advance the promise of an immunotherapy CAR-T platform and investigational treatment.

Are you interested in joining a team that is positively impacting patients' lives by ensuring high quality in our cell therapy products? Apply today for this exciting opportunity to be part of the #CAR-T team!

Supported by their direct Senior Manager, the CAR-T Cell Collection Operations Manager coordinates, and maintains virtual supplier network of apheresis and cryopreservation starting material for clinical and commercial CAR-T products. With subject matter expertise, they lead the technical relationship with Operating Company-level cell therapy teams and closely collaborate with commercial CAR-T teams. They will facilitate cell collection site certification activities related to apheresis and cell lab, support/provide training for technicians/nurses as needed and facilitate near-real-time apheresis and/or cryopreservation quality investigation when required.

The Manager is responsible for effectively collaborating with "hospitals as suppliers" and completes appropriate technical analysis to assure quality services. They will maintain positive collaborations with other operation groups, identifying options to improve performance. The Manager may implement programs to reduce supply base and achieve cost reduction goals. They will lead supplier capabilities including capacity planning and inventory management. This role provides global and multi-site support.

Key Responsibilities:

• Manage and maintain commercial CAR-T apheresis and cryopreservation activities in support of 2500-3000 CAR-T patient commercial supply chain activities.


• Serve as primary POC for apheresis center, local cryopreservation cell laboratories, as well as, contracted third party apheresis/cryopreservation centers within assigned regions.


• Serve as apheresis Subject Matter Authority for internal and external teams.


• Facilitate and conduct site qualification and training for collections and/or cryopreservation requirements.


• Activate site as approved supplier, prior to First Patient In (FPI) date.


• Ensure timely receipt of recall communications from apheresis centers and evaluate impact to product quality.


• Ensure timely release of quality fresh/cryopreserved apheresis starting material.


• Complete quality issues management within 24-48 hours post apheresis.


• Complete risk and change management.


• Develop solid understanding of information technology, logistic transport and regulatory requirements affecting collection and cryopreservation of apheresis starting material.


• Maintain metrics to manage site performance.